Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Induced mesenchymal stem cell therapy - Eterna Therapeutics

Next Previous
X
Search
Drug Profile

Induced mesenchymal stem cell therapy - Eterna Therapeutics

Alternative Names: iPSC-Derived iMSCs - Eterna Therapeuics

Latest Information Update: 19 Nov 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Eterna Therapeutics
  • Class Gene therapies; Mesenchymal stem cell therapies
  • Mechanism of Action Cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Multiple sclerosis

Most Recent Events

  • 29 Aug 2024 Preclinical trials in Multiple sclerosis in USA (Parenteral) before August 2024 (Eterna Therapeutics pipeline, August 2024)
  • 30 Apr 2024 Eterna Therapeutics has patent protection for mRNA cell reprogramming technology in USA, Australia, China, Europe, Japan, Mexico, and Russia and other countries as of April 2024

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top